Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,253,299
+$5,298,275 QoQ
Shares Held
3,114,314
+30.8% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. ANNX ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in ANNX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,253,299 | 3,114,314 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,955,024 | 2,381,479 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,746,564 | 572,644 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,019,328 | 424,720 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,422,927 | 737,268 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,366,838 | 461,372 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,542,989 | 429,559 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,193,730 | 447,700 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $106,159 | 14,806 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $501,951 | 130,377 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $248,723 | 48,109 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $133,648 | 21,626 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $106,770 | 28,321 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $227,846 | 10,122 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||